Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
1988-1-26
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0025-7753
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
24
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
572
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3121961-Anti-Bacterial Agents,
pubmed-meshheading:3121961-Cross Infection,
pubmed-meshheading:3121961-Humans,
pubmed-meshheading:3121961-Microbial Sensitivity Tests,
pubmed-meshheading:3121961-Pseudomonas Infections,
pubmed-meshheading:3121961-Pseudomonas aeruginosa,
pubmed-meshheading:3121961-Sepsis
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Does a rational therapeutic plan exist for nosocomial bacteremia caused by Pseudomonas aeruginosa?].
|
pubmed:publicationType |
Journal Article,
Comparative Study
|